Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superiority of Hedrin 4% dimeticone vs Derbac-M 0.5% malathion for treatment of head lice
2006-004136-73Phase 3Completed
- Sponsor
- Thornton & Ross
- Start
- Feb 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dimeticone in pediculosis capitis (2 arms), sponsored by Thornton & Ross. Primary endpoint: Absence of active head lice infestation at day 14. Started Feb 2012; status: completed.
02
Drugs
dimeticone
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on 2006-004136-73.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004136-73.